---

Obstructive Lung Disease - Long Answer Questions (Robbins Pathology)

---

OVERVIEW

1. Emphysema
2. Chronic Bronchitis (together forming COPD)
3. Asthma
4. Bronchiectasis

---

FLOWCHART 1 - Classification of Obstructive Lung Diseases

OBSTRUCTIVE LUNG DISEASE
         |
    _____|_____________________
    |                         |
   COPD                    OTHER
    |                         |
  __|__________           ____|______
  |            |          |         |
Emphysema  Chronic     Asthma   Bronchiectasis
           Bronchitis
  |            |
Acinar      Mucus gland
destruction  hypertrophy
(permanent) + hypersecretion

---

1. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

• Affects >10% of U.S. adults over age 40
• 4th leading cause of death in the USA; 3rd worldwide
• 35-50% of heavy smokers develop COPD
• ~80% of COPD is attributable to smoking
• Women appear more susceptible than men

• Cigarette smoking (primary)
• Poor lung development early in life
• Environmental/occupational pollutants
• Airway hyperresponsiveness
• Genetic polymorphisms (e.g., alpha-1 antitrypsin deficiency)

---

2. EMPHYSEMA

Definition

Classification (4 Types)

Only centriacinar and panacinar types are associated with COPD. Centriacinar is ~20x more common.

---

FLOWCHART 2 - Pathogenesis of Emphysema

Cigarette Smoke / Noxious Stimuli
            |
            v
   Recruitment of Neutrophils & Macrophages
            |
   _________|_________
   |                 |
Elastase         Oxidants (ROS)
(Neutrophil)     |
   |             v
   |         Inactivate
   |         Alpha-1 Antitrypsin (AAT)
   |                 |
   |_________________|
            |
            v
    IMBALANCE: Protease >> Antiprotease
            |
            v
   Destruction of Elastin in Alveolar Wall
            |
            v
   Permanent Air Space Enlargement
   (Loss of elastic recoil)
            |
            v
   Air Trapping → Hyperinflation → EMPHYSEMA

• Smoking attracts neutrophils/macrophages → release elastase and other proteases
• Smoking also generates ROS that inactivate alpha-1 antitrypsin (AAT), the main inhibitor of elastase
• In AAT deficiency: even without smoking, uncheck elastase destroys alveolar walls → panacinar emphysema

Morphology

• Gross: Pale, voluminous lungs; may not deflate on opening chest; bullae in distal/paraseptal type
• Microscopic: Enlargement and destruction of air spaces; thinning/loss of alveolar walls; reduction in capillary bed

Clinical Features

• Progressive dyspnea (main symptom)
• Barrel-chest, pursed-lip breathing, use of accessory muscles
• "Pink Puffer" phenotype (predominantly emphysema): thin, dyspneic, maintain normal PaO2 by hyperventilation
• PFTs: ↓ FEV1, ↓ FEV1/FVC, ↑ TLC, ↑ RV, ↓ DLCO
• CXR: Hyperinflation, flattened diaphragm, increased AP diameter

---

3. CHRONIC BRONCHITIS

Definition (Clinical)

Pathogenesis

Cigarette Smoke / Irritants
          |
          v
  Hypertrophy of Mucus-Secreting Glands
  + Goblet Cell Metaplasia
          |
          v
  Excess Mucus Production
          |
          v
  Mucociliary Clearance Impaired
          |
     _____|_____
     |         |
 Mucus plug  Secondary
 obstruction  Bacterial
              Infection
          |
          v
  Chronic Airway Inflammation
  (neutrophils, macrophages, lymphocytes)
          |
          v
  Small Airway Disease (bronchiolitis)
          |
          v
  Airflow Obstruction

Morphology

• Gross: Hyperemic, swollen mucosa; mucus hypersecretion; luminal narrowing
• Microscopic:
  • Hypertrophy of submucosal glands (increased Reid Index - ratio of gland layer to bronchial wall thickness; normally < 0.4; in chronic bronchitis > 0.5)
  • Goblet cell metaplasia of surface epithelium
  • Inflammatory infiltrate (neutrophils, lymphocytes, macrophages) in airway wall
  • Small airway disease: fibrosis, smooth muscle hypertrophy in bronchioles

Reid Index

• Normal: < 0.4
• Chronic Bronchitis: > 0.5 (increased due to mucous gland hypertrophy)

Clinical Features

• "Blue Bloater" phenotype (predominantly chronic bronchitis): obese, cyanotic, hypercapnic, hypoxemic, prone to cor pulmonale
• Frequent respiratory infections
• Hypoxia → polycythemia → cor pulmonale
• PFTs: ↓ FEV1/FVC; relatively normal TLC and RV (less air trapping than emphysema)

---

FLOWCHART 3 - Comparison: Emphysema vs. Chronic Bronchitis

Feature            Emphysema ("Pink Puffer")   Chronic Bronchitis ("Blue Bloater")
------------------  --------------------------  ------------------------------------
Mechanism          Alveolar wall destruction    Mucus hypersecretion + airway inflam.
Primary site       Acini (distal airspace)      Large + small airways
Definition basis   Pathological                 Clinical
Morphology         Enlarged air spaces          Gland hypertrophy (Reid Index >0.5)
Body habitus       Thin, barrel-chested         Obese
Cyanosis           Absent (late)                Present early
PaO2               Relatively normal            Reduced (hypoxemia)
PaCO2              Normal / slightly low        Elevated (hypercapnia)
Cor pulmonale      Late                         Early/common
Infections         Less common                  Frequent
Sputum             Minimal                      Copious purulent
Key test finding   ↓ DLCO                       Normal/slightly ↓ DLCO

---

4. ASTHMA

Definition

Hallmarks (Robbins)

1. Intermittent, reversible airway obstruction
2. Chronic bronchial inflammation with eosinophils
3. Bronchial smooth muscle hypertrophy and hyperreactivity
4. Increased mucus secretion

---

FLOWCHART 4 - Pathogenesis of Atopic (Allergic) Asthma

FIRST EXPOSURE TO ALLERGEN
          |
          v
  Antigen processed by Dendritic Cells
          |
          v
  Activation of Th2 CD4+ T cells
          |
  _________|___________________________
  |             |                    |
 IL-4/IL-13   IL-5              Eotaxin
  |             |                    |
  v             v                    v
 IgE           Eosinophil        Eosinophil
 Production    Activation       Recruitment
 by B cells
  |
  v
 IgE binds Fc receptors on Mast Cells
  
SECOND EXPOSURE (Re-exposure to Allergen)
          |
          v
  Allergen cross-links IgE on Mast Cells
          |
     _____|_________________________________________
     |                                             |
IMMEDIATE PHASE (minutes)              LATE PHASE (hours)
     |                                             |
Mast cell degranulation               Recruitment of eosinophils,
- Histamine                           neutrophils, basophils,
- Leukotrienes (LTC4, LTD4)          Th2 cells, monocytes
- Prostaglandins (PGD2)                            |
- PAF, TNF                            Eosinophils release:
     |                                - Major Basic Protein (MBP)
     v                                - Eosinophil Cationic Protein (ECP)
Bronchoconstriction                   - Galectin-10 (Charcot-Leyden crystals)
Increased vascular permeability                    |
Mucus production                       v
Vagal reflex stimulation          Airway Remodeling
                                  (chronic changes)

---

Types of Asthma

Morphology (Pathological Changes)

• Lungs distended due to air trapping
• Occlusion of bronchi/bronchioles by thick mucous plugs containing Curschmann spirals (whorls of shed epithelium)
• Numerous eosinophils and Charcot-Leyden crystals (formed from galectin-10 released by eosinophils)

• Thickening of airway wall
• Subbasement membrane fibrosis
• Increased submucosal vascularity
• Hypertrophy of submucosal glands + goblet cell metaplasia
• Hypertrophy/hyperplasia of bronchial muscle

Clinical Features

• Episodic: severe dyspnea + wheezing (usually 1 to several hours)
• Between attacks: symptom-free (PFTs may still show subtle deficits)
• Status asthmaticus: severe attack unresponsive to therapy for days/weeks; hypercapnia, acidosis, severe hypoxia; potentially fatal
• PFTs during attack: ↓ FEV1, ↓ FEV1/FVC, ↑ TLC, ↑ RV (reversible with bronchodilators - key differentiator from COPD)

Treatment

• Mild: bronchodilators (beta-agonists) + glucocorticoids ± leukotriene inhibitors
• Severe/elevated eosinophils/high IgE: biologic agents targeting IL-4, IL-5, IgE (e.g., mepolizumab, omalizumab)

---

5. BRONCHIECTASIS

Definition

Note: It is not a primary disorder - always secondary to persistent infection or obstruction.

Predisposing Conditions

CAUSES OF BRONCHIECTASIS
         |
  _______|_______________________________
  |              |                      |
Obstruction   Congenital/            Necrotizing
              Hereditary             Infections
  |              |                      |
Tumors         Cystic Fibrosis      Staphylococcal
Foreign body   (viscid mucus)       Klebsiella
Mucus impaction Immunodeficiency     Mycobacteria
(asthma, ABPA)  (Ig deficiency)      (TB)
               Kartagener syndrome    Fungal
               (immotile cilia)
               Young syndrome

• Bronchial obstruction: Tumors, foreign bodies, mucus impaction (asthma, chronic bronchitis)
• Congenital/hereditary:
  • Cystic fibrosis (viscid mucus + secondary infections)
  • Immunodeficiency states (Ig deficiencies)
  • Kartagener syndrome (immotile cilia - defective ciliary motility)
  • Young syndrome
• Postinfectious:
  • Necrotizing pneumonias (Staphylococcus, Klebsiella, Mycobacterium, fungi, Aspergillus - ABPA)
  • Measles, pertussis in children

FLOWCHART 5 - Pathogenesis of Bronchiectasis

Persistent Obstruction OR Necrotizing Infection
              |
              v
     Impaired Mucociliary Clearance
              |
              v
   Accumulation of Secretions / Infection
              |
              v
   Cycle of Inflammation & Infection
              |
              v
   Neutrophil recruitment → Protease release
              |
              v
   Destruction of bronchial wall
   (smooth muscle + elastic tissue)
              |
              v
   PERMANENT DILATION of bronchi/bronchioles
              |
              v
   Further impaired drainage → More infection
   (vicious cycle)

Morphology

• Gross: Dilated bronchi up to 4x normal diameter; may extend to pleural surface; pus-filled airways; lower lobes involved (except TB - upper lobes)
• Microscopic:
  • Intense acute and chronic inflammatory exudate within bronchial walls
  • Desquamation of lining epithelium → ulceration
  • Fibrosis of bronchial wall and peribronchial fibrosis
  • In areas of fibrosis: atelectasis of surrounding lung
  • Vascular changes: bronchial artery dilatation

Clinical Features

• Symptoms:
  • Persistent cough with copious purulent, foul-smelling sputum (hallmark)
  • Hemoptysis (sometimes the presenting feature)
  • Recurrent fever, weight loss
  • Progressive dyspnea
• Signs:
  • Clubbing of fingers
  • Coarse crackles on auscultation
  • Cor pulmonale (in severe, long-standing disease)
• Complications:
  • Cor pulmonale
  • Secondary amyloidosis
  • Metastatic brain abscess
  • Empyema (if pleura involved)
• Diagnosis: HRCT chest (gold standard) - "tram-track" sign, signet ring sign

---

MASTER SUMMARY FLOWCHART - Obstructive Lung Disease

OBSTRUCTIVE LUNG DISEASE
         |
         |--- COPD (irreversible obstruction)
         |        |
         |        |--- EMPHYSEMA
         |        |      Mechanism: Protease-antiprotease imbalance
         |        |      Site: Alveoli (air space destruction)
         |        |      Key: ↓ DLCO, Pink Puffer, ↑ TLC
         |        |
         |        |--- CHRONIC BRONCHITIS
         |               Mechanism: Mucus hypersecretion
         |               Site: Large airways (mucous glands)
         |               Key: Reid Index >0.5, Blue Bloater, Cor pulmonale
         |
         |--- ASTHMA (reversible obstruction)
         |        Mechanism: Th2/IgE → Mast cell → Bronchoconstriction
         |        Site: Bronchi + bronchioles
         |        Key: Eosinophils, reversible on bronchodilators
         |        Types: Atopic, Nonatopic, Occupational, Drug-induced
         |
         |--- BRONCHIECTASIS (permanent bronchial dilation)
                  Mechanism: Chronic infection/obstruction → wall destruction
                  Site: Bronchi/bronchioles
                  Key: Purulent copious sputum, clubbing, HRCT diagnosis

---

KEY DISTINGUISHING FEATURES TABLE

---